(Q35854808)

10 August 2017

1 reference

title

Antagonizing the angiotensin II subtype 1 receptor: a focus on olmesartan medoxomil (English)

1 reference

10 August 2017

Jürg Nussberger

1

1 reference

10 August 2017

Hiroyuki Koike

series ordinal

2

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

published in

Clinical Therapeutics

1 reference

10 August 2017

volume

26 Suppl A

1 reference

10 August 2017

page(s)

A12-20

1 reference

Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990141-5

7 January 2021

Neurohormonal modulation in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990141-5

7 January 2021

Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990141-5

7 January 2021

Plasma bradykinin in angio-oedema.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990141-5

7 January 2021

In vitro and in vivo pharmacology of olmesartan medoxomil, an angiotensin II type AT1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990141-5

7 January 2021

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990141-5

7 January 2021

Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990141-5

7 January 2021

Bradykinin-mediated angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990141-5

7 January 2021

10.1016/S0149-2918(04)90141-5

Identifiers

DOI

1 reference

10 August 2017

1 reference